Company

Company

Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Allife Medical Science and Technology

Main focus: Next generation cellular therapies

Company stage: Clinical

Diseases: Beta-thalassemia, haematological and solid tumours

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: Beijing, China

Website: http://www.allifetech.com/

Allife Medical Science and Technology is a company focused on developing next generation cellular therapies for the treatment of genetic diseases and cancers. The company uses CRISPR to genetically modify its cellular products, and currently runs multiple clinical trials.

Allife Medical Science and Technology Co., Ltd

Your Latest CMN News

CMN Weekly (19 April 2024) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

A Secondary Checkpoint Refines CRISPR Precision

New findings highlight a secondary conformational checkpoint in CRISPR-Cas9 that significantly enhances its accuracy in gene editing.

Cancer's Weak Point Is Its Metabolism, CRISPR...

American researchers have developed a novel CRISPR-based platform to identify and characterise essential nutrient transporters that support cancer...

Next-Generation CRISPR Screening Libraries Without...

Sponsored content

Founded in 2018, Vivlion is a spin-out of Goethe University Frankfurt. Its mission is to provide innovative gene-editing reagents and screening...

CMN Weekly (12 April 2024) - Your Weekly CRISPR...

Some of the best links we picked up around the internet

Scientists use CRISPR to develop new detection...

Scientists in China describe a sensitive and selective CRISPR-Cas12-based assay for the detection of a protein that is implicated in obesity and...

Company: Allife Medical Science and Technology

Search CRISPR Medicine